- Home
- SUPN vs DQ Comparison
SUPN vs DQ Comparison
Compare SUPN & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- DQ
- Stock Information
- Founded
- SUPN 2005
- DQ 2006
- Country
- SUPN United States
- DQ China
- Employees
- SUPN N/A
- DQ N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- DQ Semiconductors
- Sector
- SUPN Health Care
- DQ Technology
- Exchange
- SUPN Nasdaq
- DQ Nasdaq
- Market Cap
- SUPN 1.7B
- DQ 1.4B
- IPO Year
- SUPN 2012
- DQ 2010
- Fundamental
- Price
- SUPN $31.70
- DQ $13.10
- Analyst Decision
- SUPN Hold
- DQ Hold
- Analyst Count
- SUPN 2
- DQ 6
- Target Price
- SUPN $36.00
- DQ $20.31
- AVG Volume (30 Days)
- SUPN 420.5K
- DQ 839.6K
- Earning Date
- SUPN 05-06-2025
- DQ 04-29-2025
- Dividend Yield
- SUPN N/A
- DQ N/A
- EPS Growth
- SUPN N/A
- DQ N/A
- EPS
- SUPN 1.11
- DQ N/A
- Revenue
- SUPN $667,997,000.00
- DQ $737,683,000.00
- Revenue This Year
- SUPN N/A
- DQ N/A
- Revenue Next Year
- SUPN $9.14
- DQ $66.29
- P/E Ratio
- SUPN $28.49
- DQ N/A
- Revenue Growth
- SUPN 11.82
- DQ N/A
- 52 Week Low
- SUPN $25.53
- DQ $12.41
- 52 Week High
- SUPN $40.28
- DQ $30.85
- Technical
- Relative Strength Index (RSI)
- SUPN 47.88
- DQ 38.10
- Support Level
- SUPN $29.16
- DQ $12.72
- Resistance Level
- SUPN $33.28
- DQ $13.45
- Average True Range (ATR)
- SUPN 1.19
- DQ 0.70
- MACD
- SUPN 0.02
- DQ 0.14
- Stochastic Oscillator
- SUPN 61.65
- DQ 23.87
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.